Member Info for gje306

There you go again 😂 Why would you voluntarily dredge up your own example of spouting horsesh*t? Now back it up with something factual. Have you spoken to CC about this, or are you in fact just making it up?

These internal compliance teams are pretty toothy these days, so hopefully they will uphold this complaint.

Good to see someone taking some action:

https://twitter.com/pau79021/status/1786407762643046491/photo/1

Founded in Q3 of 2005, GSA Capital Partners is a London-based quantitative hedge fund manager. It focuses on systematic trading across liquid equity, futures, and foreign exchange markets globally. The firm was formed in 2001 as the global statistical arbitrage group of DB Advisors, a proprietary trading unit of Deutsche Bank. It spun out of the bank in 2005 to create an independent hedge fund management company.

What a bunch of c***s.

He's blowing hot now because he was called out for lying. He'll be back with his negative lies soon enough.

no vendetta, just fed up with your constant pack of lies and horse****, as are most people on here. hide behind your green boxes - your horsesh*t will continue to be flagged.

I do wonder how many are currently sitting on the side lines waiting to buy in. I suspect when this moves it will do so pretty swiftly.

Don't agree with that gmcc. What you are describing is just an accountant preparing the accounts. A CFO is supposed to be the money person who understands the financial requirements of the company, has links with the investment community and steers them through fundraises.

From a couple of websites:

Rolls of a CFO:

"1) growing the company faster, 2) improving profitability, 3) improve cash flow, 4) obtain increased leverage from banks, and 5) provide leadership and direction throughout the company"

"

What does a CFO do in a company?

CFOs make sensible and successful financial decisions that work in the business’s favor to increase revenue and profitability.

The role of the CFO is varied and can include:

Advising on financial best-practice

Guiding on policy and compliance

Securing investment

Getting the business ready for IPO (Initial Public Offering)

Matching the finance team’s talent strategy with the needs of the business

Deciding on financial systems, processes, and technology "

Our CFO failed in these respects.

Yes touk, I am accusing you of making stuff up. Feel free to back this comment up.

If they went mad for this inferior approach, what will happen when PDC's become the next hot property.

The short is tiny, it won't move the dial either way.

Touk, we ignore your posts because you don't watch the presentations, or at least are unable to interpret them, and you make stuff up.

Https://x.com/cumulus51896691/status/1786072627511001481?s=46&t=A543JZMlg2Q8YTCvlVat_w

“However, despite recent successes, the clinical development of ADCs has been associated with a high failure rate, as off-site toxicity remains problematic, limiting tolerable ADC doses to levels below those required for substantial anti-cancer efficacy [7,8,9,10]. Even for the ADCs that have gained FDA approval, a significant fraction of treated patients require supportive treatment to reduce the severity of ADC-associated toxicities, and many patients require dose reduction, treatment delays, or treatment discontinuation”

Wouldn’t that require director sharedealing rns?

let's just break this down shall we. you said:

"the exceptional clinical results are no more exceptional than that extrapolated from the mouse trials."

what's the point in this comment exactly? this is like saying messi's exceptional ability in the second half of the match was no more exceptional than his ability in the second half. why the **** would anyone say that? but anyway, i think i understand what you are saying is that the results in both the mouse trials and the p1a phase so far are exceptional. we can agree on that despite the bizarre turn of phrase.

you said:

"chris made a point that the amount of dox in the tumour was not directly proportional to fap present so why is there such a range of tumour shrinkage or in some cases continuing growth?"

you also said:

"look at the f*cking slide"

that's great advice, which you seem to have ignored yourself. multiple times ice has told you the reason, multiple times you keep on ignoring the reply. watch the ******* presentation. keep watching it until it sinks in.

just so you are clear:

what the data tells us in that slide is that precision is working "its magic" in high and mid fap tumours and is resulting in dox, or indeed whatever warhead you choose to attach, concentrating in the tumour. cc went on to say that in the patients treated so far, the responses correlated with tumours that were known to respond to dox, and it just so happened that these were also the ones high in fap.

the overwhelmingly positive takeaway from this is that we are likely to see ava6000 being efficacious in dox sensitive tumours that are both high and mid fap!

come on touk, haven't got all day.... back up your statements, or caveat it with "i made this **** up" perhaps?

Touk, are you back making stuff up again?

I don't believe they can run the various dose levels in parallel, only patients within a dose cohort. Again, ambiguous comms lead to these kinds of debates.

Thorn, that quote was taken from an RNS at the beginning of the trial, and clearly the design and circumstances changed along the way. Now I agree this is where comms have been a bit of a let down to say the least, and does smack a bit of arrogance on the part of management at the time that they didn't feel the need to keep shareholders updated on changes and the motivation behind them, and also to maintain realistic expectations. I sincerely hope this is where we are going to see improvements from CC, because any more of this chicanery will just result in her inheriting all of AS's legacy in this regard.

Touk, now that you're back would you care to comment on the below, or are you just going to continue hanging around making up rubbish?

It is odd Ben. The statement may or may not be true, however, without backing it up, I can only assume that they are making stuff up, which is not a commendable trait.